Centers

Centre for Collaborative Drug Research

Chulalongkorn University Drug Discovery and Drug Development Research Center (Chula4DR)

Saint Louis University Institute for Drug and Biotherapeutic Innovation (IDBI)

The Centre for Collaborative Drug Research is a multidisciplinary initiative bringing together the Faculties of Medicine and Pharmacy at the University of Toronto, Canadas leading academic institution and largest research entity, and the Centre...

Read more
Chulalongkorn Drug Discovery and Drug Development Research Center (Chula4DR) was established in 2017, with the aim to facilitate advancement of academic drug discovery and drug development research by leveraging innovations and sciences...
Read more

 

The IDBI is a decentralized, collaborative institute whose mission is to promote the translation of research projects at Saint Louis University through drug discovery and pre-clinical development. The IDBI achieves this through four main...

Read more

Partnerships

Events

Jobs

Yale to Partner with Gilead to Further Cancer Research

Yale and Gilead have entered into a multi-year research collaboration to develop new treatments against cancer. Gilead will provide $40million in funding for research and other infrastructure support for the initial four years. The agreement can...

 
View all

Johns Hopkins BSi Licenses GCPII Assets from Eisai

Johns Hopkins Brain Science Institute ("BSi") has taken a non-exclusive license from Eisai to develop new compounds related to Glutamate Carboxypeptidase II (GCP-II) technology. The new compounds developed under this license will be targeted...

 
View all

TB Drug Accelerator

  • The TB Drug Accelerator Programme aims to speed up the discovery and development of novel compounds against tuberculosis (TB).

 
View all

No EVENTS for listing

No Job Posts

Sponsors

Pfizer Roche HL Tocris Sigma-Aldrich Xenotech Xenotech Eurofins Pfizer Roche HL Tocris Sigma-Aldrich Xenotech Xenotech Eurofins
View All